Wikipedia -WSS

Wikipedia

author：fashion 2025-10-02 21:05:36 - browse：5599

Treeline Northwest — AP Photo/Ted S. Warren

Josh Bilenker’s last company, Loxo Oncology, was purchased by Eli Lilly for $8 billion. No surprise, then, that his next effort has already raised at least $473 million in funding from private investors even before telling the public what, exactly, it is working on.

Treeline Biosciences, the new venture by Bilenker and Jeffrey Engelman, formerly Novartis’s top cancer researcher, has hired more than 130 people across three research sites in little more than a year, according to a company blog post, regulatory filings, and STAT reporting.

Treeline’s website doesn’t mention a single drug target or disease. In a paper published last year in Nature Cancer, Engelman and several colleagues reviewed the history of a class of cancer drugs called PI3 kinase inhibitors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Fight over Supreme Court dialysis ruling puts kidney patients at risk

WSS

Finland to offer bird flu vaccine to select groups of people, a possible global first

How housing is health care on Long Island

New Covid vaccine is recommended for everyone 6 months or older

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

PEPFAR is under serious threat — and so is global health

WATCH: Why do bright lights make us see spots?

entertainment

Wikipedia

entertainment

Continuity nursing helped my family in our darkest PICU moments

Acelyrin, a rare IPO success, stumbles in its first big test

How one medical school became remarkably diverse

Generate Biomedicines machine learning biotech raises $273M

Sports medicine is finally prioritizing gender equality

What to make of Biden’s latest efforts on cancer research

Virginia high school admissions case could be legal follow

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

Medicare details structure of new drug price negotiation program

Fight over Supreme Court dialysis ruling puts kidney patients at risk

focus

Regeneron agrees to White House price limits on anti

FDA approves updated Covid vaccines

CMS got Medicare Advantage quality rating wrong, judge rules

A new initiative will help leaders fight the next pandemic

What to make of Biden’s latest efforts on cancer research

UnitedHealth CEO's Medicaid comments send insurer stocks diving

entertainment

focus

entertainment

Wikipedia